SCHEMBL26415419

SCHEMBL26415419

c1ccc(-c2ccc(N(c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4c(c3)oc3ccccc34)c3ccc4oc5ccccc5c4c3)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.33
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 2/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
CHEK2 O96017 1/20 0.32
POLB P06746 2/20 0.32
NR1H4 Q96RI1 1/20 0.31
TSHR P16473 3/20 0.31
KDM1A O60341 1/20 0.31
ALOX15 P16050 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22112409 0.94 ALDH1A1 (0.34) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL24255426 0.93 ALDH1A1 (0.34) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL24255395 0.93 ALDH1A1 (0.34) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL24066078 0.91 MMP12 (0.33) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL24899569 0.90 KDM4E (0.34) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL25975499 0.90 ALDH1A1 (0.32) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL24066080 0.90 TSHR (0.33) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL22112415 0.90 ALDH1A1 (0.36) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL24256037 0.90 ALDH1A1 (0.31) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL19129987 0.89 MAPT (0.34) MAPTALDH1A1KDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 MAPT 950/4885ALDH1A1 27/4885KDM4E 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.